Overview
Ayman Alhejazi practices in Riyadh, Saudi Arabia. Mr. Alhejazi is rated as an Experienced expert by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Erdheim-Chester Disease, Bone Marrow Transplant, and Tissue Biopsy.
His clinical research consists of co-authoring 55 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Hemolytic Anemia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Classical Hodgkin LymphomaMr. Alhejazi isDistinguished. Learn about Classical Hodgkin Lymphoma.
- Advanced
- Erdheim-Chester DiseaseMr. Alhejazi isAdvanced. Learn about Erdheim-Chester Disease.
- Hodgkin LymphomaMr. Alhejazi isAdvanced. Learn about Hodgkin Lymphoma.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Mr. Alhejazi isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloid Leukemia (AML)Mr. Alhejazi isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AnemiaMr. Alhejazi isExperienced. Learn about Anemia.
- B-Cell LymphomaMr. Alhejazi isExperienced. Learn about B-Cell Lymphoma.
- Bone Marrow TransplantMr. Alhejazi isExperienced. Learn about Bone Marrow Transplant.
- Chronic Graft Versus Host Disease (cGvHD)Mr. Alhejazi isExperienced. Learn about Chronic Graft Versus Host Disease (cGvHD).